Global Inhalation Sevoflurane Anaesthetic Agent Market Research Report 2026(Status and Outlook)
Sevoflurane is a volatile anesthetic commonly used for induction and maintenance of general anesthesia during surgical procedures. It is favored for its rapid onset and offset of action, making it ideal for both adults and pediatric patients. Sevoflurane is typically inhaled and works by depressing the central nervous system, leading to a reversible loss of consciousness and sensation. Its minimal airway irritation and low blood solubility contribute to smoother anesthesia induction and quicker recovery times compared to other anesthetics. Sevoflurane is widely used due to its safety profile and ease of administration.The key driver for the Sevoflurane market is the increasing number of surgeries worldwide, driven by the aging population and the rising prevalence of chronic conditions requiring surgical intervention. Sevoflurane is highly preferred due to its rapid onset and recovery, making it ideal for both pediatric and adult patients, particularly in outpatient surgeries. Technological advancements in anesthesia delivery systems and the growing demand for minimally invasive procedures have also contributed to the rising adoption of Sevoflurane in clinical settings. Furthermore, the safety and effectiveness of Sevoflurane in maintaining stable cardiovascular function during anesthesia have enhanced its demand.One of the main challenges in the Sevoflurane market is its high cost compared to other anesthetic agents, which can limit its accessibility in low- and middle-income regions. Additionally, environmental concerns regarding the use of volatile anesthetics like Sevoflurane, which contribute to greenhouse gas emissions, have led to increased scrutiny and calls for more sustainable alternatives. Regulatory restrictions and the availability of generic alternatives may further impact the market growth, as healthcare providers seek more cost-effective or environmentally friendly options.
The global Sevoflurane market size was estimated at USD 1195.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 3.60% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Sevoflurane market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Sevoflurane market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Sevoflurane market.
Global Sevoflurane Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Hengrui
Baxter
Maruishi
AbbVie
Piramal
Viatris
PT Novell Pharmaceutical
Lunan Pharma
Market Segmentation (by Type)
Generic Drug
Original Drug
Market Segmentation (by Application)
Hospital
Clinics
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Sevoflurane Market
Overview of the regional outlook of the Sevoflurane Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Sevoflurane Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Sevoflurane, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Sevoflurane market size was estimated at USD 1195.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 3.60% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Sevoflurane market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Sevoflurane market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Sevoflurane market.
Global Sevoflurane Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Hengrui
Baxter
Maruishi
AbbVie
Piramal
Viatris
PT Novell Pharmaceutical
Lunan Pharma
Market Segmentation (by Type)
Generic Drug
Original Drug
Market Segmentation (by Application)
Hospital
Clinics
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Sevoflurane Market
Overview of the regional outlook of the Sevoflurane Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Sevoflurane Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Sevoflurane, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Inhalation Sevoflurane Anaesthetic Agent
1.2 Key Market Segments
1.2.1 Inhalation Sevoflurane Anaesthetic Agent Segment by Type
1.2.2 Inhalation Sevoflurane Anaesthetic Agent Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Inhalation Sevoflurane Anaesthetic Agent Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Inhalation Sevoflurane Anaesthetic Agent Product Life Cycle
3.3 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Manufacturers (2020-2025)
3.4 Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Manufacturers (2020-2025)
3.5 Inhalation Sevoflurane Anaesthetic Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Inhalation Sevoflurane Anaesthetic Agent Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Inhalation Sevoflurane Anaesthetic Agent Market Competitive Situation and Trends
3.8.1 Inhalation Sevoflurane Anaesthetic Agent Market Concentration Rate
3.8.2 Global 5 and 10 Largest Inhalation Sevoflurane Anaesthetic Agent Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 INHALATION SEVOFLURANE ANAESTHETIC AGENT INDUSTRY CHAIN ANALYSIS
4.1 Inhalation Sevoflurane Anaesthetic Agent Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Inhalation Sevoflurane Anaesthetic Agent Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Inhalation Sevoflurane Anaesthetic Agent Market
5.7 ESG Ratings of Leading Companies
6 INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type (2020-2025)
6.3 Global Inhalation Sevoflurane Anaesthetic Agent Market Size by Type (2020-2025)
6.4 Global Inhalation Sevoflurane Anaesthetic Agent Price by Type (2020-2025)
7 INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Inhalation Sevoflurane Anaesthetic Agent Market Sales by Application (2020-2025)
7.3 Global Inhalation Sevoflurane Anaesthetic Agent Market Size (M USD) by Application (2020-2025)
7.4 Global Inhalation Sevoflurane Anaesthetic Agent Sales Growth Rate by Application (2020-2025)
8 INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SALES BY REGION
8.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Region
8.1.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Region
8.1.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Region
8.2 Global Inhalation Sevoflurane Anaesthetic Agent Market Size by Region
8.2.1 Global Inhalation Sevoflurane Anaesthetic Agent Market Size by Region
8.2.2 Global Inhalation Sevoflurane Anaesthetic Agent Market Size by Region
8.3 North America
8.3.1 North America Inhalation Sevoflurane Anaesthetic Agent Sales by Country
8.3.2 North America Inhalation Sevoflurane Anaesthetic Agent Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Country
8.4.2 Europe Inhalation Sevoflurane Anaesthetic Agent Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Sales by Region
8.5.2 Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Inhalation Sevoflurane Anaesthetic Agent Sales by Country
8.6.2 South America Inhalation Sevoflurane Anaesthetic Agent Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Sales by Region
8.7.2 Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET PRODUCTION BY REGION
9.1 Global Production of Inhalation Sevoflurane Anaesthetic Agent by Region(2020-2025)
9.2 Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Region (2020-2025)
9.3 Global Inhalation Sevoflurane Anaesthetic Agent Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Inhalation Sevoflurane Anaesthetic Agent Production
9.4.1 North America Inhalation Sevoflurane Anaesthetic Agent Production Growth Rate (2020-2025)
9.4.2 North America Inhalation Sevoflurane Anaesthetic Agent Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Inhalation Sevoflurane Anaesthetic Agent Production
9.5.1 Europe Inhalation Sevoflurane Anaesthetic Agent Production Growth Rate (2020-2025)
9.5.2 Europe Inhalation Sevoflurane Anaesthetic Agent Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Inhalation Sevoflurane Anaesthetic Agent Production (2020-2025)
9.6.1 Japan Inhalation Sevoflurane Anaesthetic Agent Production Growth Rate (2020-2025)
9.6.2 Japan Inhalation Sevoflurane Anaesthetic Agent Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Inhalation Sevoflurane Anaesthetic Agent Production (2020-2025)
9.7.1 China Inhalation Sevoflurane Anaesthetic Agent Production Growth Rate (2020-2025)
9.7.2 China Inhalation Sevoflurane Anaesthetic Agent Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Hengrui
10.1.1 Hengrui Basic Information
10.1.2 Hengrui Inhalation Sevoflurane Anaesthetic Agent Product Overview
10.1.3 Hengrui Inhalation Sevoflurane Anaesthetic Agent Product Market Performance
10.1.4 Hengrui Business Overview
10.1.5 Hengrui SWOT Analysis
10.1.6 Hengrui Recent Developments
10.2 Baxter
10.2.1 Baxter Basic Information
10.2.2 Baxter Inhalation Sevoflurane Anaesthetic Agent Product Overview
10.2.3 Baxter Inhalation Sevoflurane Anaesthetic Agent Product Market Performance
10.2.4 Baxter Business Overview
10.2.5 Baxter SWOT Analysis
10.2.6 Baxter Recent Developments
10.3 Maruishi
10.3.1 Maruishi Basic Information
10.3.2 Maruishi Inhalation Sevoflurane Anaesthetic Agent Product Overview
10.3.3 Maruishi Inhalation Sevoflurane Anaesthetic Agent Product Market Performance
10.3.4 Maruishi Business Overview
10.3.5 Maruishi SWOT Analysis
10.3.6 Maruishi Recent Developments
10.4 AbbVie
10.4.1 AbbVie Basic Information
10.4.2 AbbVie Inhalation Sevoflurane Anaesthetic Agent Product Overview
10.4.3 AbbVie Inhalation Sevoflurane Anaesthetic Agent Product Market Performance
10.4.4 AbbVie Business Overview
10.4.5 AbbVie Recent Developments
10.5 Piramal
10.5.1 Piramal Basic Information
10.5.2 Piramal Inhalation Sevoflurane Anaesthetic Agent Product Overview
10.5.3 Piramal Inhalation Sevoflurane Anaesthetic Agent Product Market Performance
10.5.4 Piramal Business Overview
10.5.5 Piramal Recent Developments
10.6 Viatris
10.6.1 Viatris Basic Information
10.6.2 Viatris Inhalation Sevoflurane Anaesthetic Agent Product Overview
10.6.3 Viatris Inhalation Sevoflurane Anaesthetic Agent Product Market Performance
10.6.4 Viatris Business Overview
10.6.5 Viatris Recent Developments
10.7 PT Novell Pharmaceutical
10.7.1 PT Novell Pharmaceutical Basic Information
10.7.2 PT Novell Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Product Overview
10.7.3 PT Novell Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Product Market Performance
10.7.4 PT Novell Pharmaceutical Business Overview
10.7.5 PT Novell Pharmaceutical Recent Developments
10.8 Lunan Pharma
10.8.1 Lunan Pharma Basic Information
10.8.2 Lunan Pharma Inhalation Sevoflurane Anaesthetic Agent Product Overview
10.8.3 Lunan Pharma Inhalation Sevoflurane Anaesthetic Agent Product Market Performance
10.8.4 Lunan Pharma Business Overview
10.8.5 Lunan Pharma Recent Developments
11 INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET FORECAST BY REGION
11.1 Global Inhalation Sevoflurane Anaesthetic Agent Market Size Forecast
11.2 Global Inhalation Sevoflurane Anaesthetic Agent Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Inhalation Sevoflurane Anaesthetic Agent Market Size Forecast by Country
11.2.3 Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Market Size Forecast by Region
11.2.4 South America Inhalation Sevoflurane Anaesthetic Agent Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Inhalation Sevoflurane Anaesthetic Agent by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Inhalation Sevoflurane Anaesthetic Agent Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Inhalation Sevoflurane Anaesthetic Agent by Type (2026-2035)
12.1.2 Global Inhalation Sevoflurane Anaesthetic Agent Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Inhalation Sevoflurane Anaesthetic Agent by Type (2026-2035)
12.2 Global Inhalation Sevoflurane Anaesthetic Agent Market Forecast by Application (2026-2035)
12.2.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales (K MT) Forecast by Application
12.2.2 Global Inhalation Sevoflurane Anaesthetic Agent Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Inhalation Sevoflurane Anaesthetic Agent
1.2 Key Market Segments
1.2.1 Inhalation Sevoflurane Anaesthetic Agent Segment by Type
1.2.2 Inhalation Sevoflurane Anaesthetic Agent Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Inhalation Sevoflurane Anaesthetic Agent Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Inhalation Sevoflurane Anaesthetic Agent Product Life Cycle
3.3 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Manufacturers (2020-2025)
3.4 Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Manufacturers (2020-2025)
3.5 Inhalation Sevoflurane Anaesthetic Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Inhalation Sevoflurane Anaesthetic Agent Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Inhalation Sevoflurane Anaesthetic Agent Market Competitive Situation and Trends
3.8.1 Inhalation Sevoflurane Anaesthetic Agent Market Concentration Rate
3.8.2 Global 5 and 10 Largest Inhalation Sevoflurane Anaesthetic Agent Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 INHALATION SEVOFLURANE ANAESTHETIC AGENT INDUSTRY CHAIN ANALYSIS
4.1 Inhalation Sevoflurane Anaesthetic Agent Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Inhalation Sevoflurane Anaesthetic Agent Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Inhalation Sevoflurane Anaesthetic Agent Market
5.7 ESG Ratings of Leading Companies
6 INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type (2020-2025)
6.3 Global Inhalation Sevoflurane Anaesthetic Agent Market Size by Type (2020-2025)
6.4 Global Inhalation Sevoflurane Anaesthetic Agent Price by Type (2020-2025)
7 INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Inhalation Sevoflurane Anaesthetic Agent Market Sales by Application (2020-2025)
7.3 Global Inhalation Sevoflurane Anaesthetic Agent Market Size (M USD) by Application (2020-2025)
7.4 Global Inhalation Sevoflurane Anaesthetic Agent Sales Growth Rate by Application (2020-2025)
8 INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SALES BY REGION
8.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Region
8.1.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Region
8.1.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Region
8.2 Global Inhalation Sevoflurane Anaesthetic Agent Market Size by Region
8.2.1 Global Inhalation Sevoflurane Anaesthetic Agent Market Size by Region
8.2.2 Global Inhalation Sevoflurane Anaesthetic Agent Market Size by Region
8.3 North America
8.3.1 North America Inhalation Sevoflurane Anaesthetic Agent Sales by Country
8.3.2 North America Inhalation Sevoflurane Anaesthetic Agent Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Country
8.4.2 Europe Inhalation Sevoflurane Anaesthetic Agent Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Sales by Region
8.5.2 Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Inhalation Sevoflurane Anaesthetic Agent Sales by Country
8.6.2 South America Inhalation Sevoflurane Anaesthetic Agent Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Sales by Region
8.7.2 Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET PRODUCTION BY REGION
9.1 Global Production of Inhalation Sevoflurane Anaesthetic Agent by Region(2020-2025)
9.2 Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Region (2020-2025)
9.3 Global Inhalation Sevoflurane Anaesthetic Agent Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Inhalation Sevoflurane Anaesthetic Agent Production
9.4.1 North America Inhalation Sevoflurane Anaesthetic Agent Production Growth Rate (2020-2025)
9.4.2 North America Inhalation Sevoflurane Anaesthetic Agent Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Inhalation Sevoflurane Anaesthetic Agent Production
9.5.1 Europe Inhalation Sevoflurane Anaesthetic Agent Production Growth Rate (2020-2025)
9.5.2 Europe Inhalation Sevoflurane Anaesthetic Agent Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Inhalation Sevoflurane Anaesthetic Agent Production (2020-2025)
9.6.1 Japan Inhalation Sevoflurane Anaesthetic Agent Production Growth Rate (2020-2025)
9.6.2 Japan Inhalation Sevoflurane Anaesthetic Agent Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Inhalation Sevoflurane Anaesthetic Agent Production (2020-2025)
9.7.1 China Inhalation Sevoflurane Anaesthetic Agent Production Growth Rate (2020-2025)
9.7.2 China Inhalation Sevoflurane Anaesthetic Agent Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Hengrui
10.1.1 Hengrui Basic Information
10.1.2 Hengrui Inhalation Sevoflurane Anaesthetic Agent Product Overview
10.1.3 Hengrui Inhalation Sevoflurane Anaesthetic Agent Product Market Performance
10.1.4 Hengrui Business Overview
10.1.5 Hengrui SWOT Analysis
10.1.6 Hengrui Recent Developments
10.2 Baxter
10.2.1 Baxter Basic Information
10.2.2 Baxter Inhalation Sevoflurane Anaesthetic Agent Product Overview
10.2.3 Baxter Inhalation Sevoflurane Anaesthetic Agent Product Market Performance
10.2.4 Baxter Business Overview
10.2.5 Baxter SWOT Analysis
10.2.6 Baxter Recent Developments
10.3 Maruishi
10.3.1 Maruishi Basic Information
10.3.2 Maruishi Inhalation Sevoflurane Anaesthetic Agent Product Overview
10.3.3 Maruishi Inhalation Sevoflurane Anaesthetic Agent Product Market Performance
10.3.4 Maruishi Business Overview
10.3.5 Maruishi SWOT Analysis
10.3.6 Maruishi Recent Developments
10.4 AbbVie
10.4.1 AbbVie Basic Information
10.4.2 AbbVie Inhalation Sevoflurane Anaesthetic Agent Product Overview
10.4.3 AbbVie Inhalation Sevoflurane Anaesthetic Agent Product Market Performance
10.4.4 AbbVie Business Overview
10.4.5 AbbVie Recent Developments
10.5 Piramal
10.5.1 Piramal Basic Information
10.5.2 Piramal Inhalation Sevoflurane Anaesthetic Agent Product Overview
10.5.3 Piramal Inhalation Sevoflurane Anaesthetic Agent Product Market Performance
10.5.4 Piramal Business Overview
10.5.5 Piramal Recent Developments
10.6 Viatris
10.6.1 Viatris Basic Information
10.6.2 Viatris Inhalation Sevoflurane Anaesthetic Agent Product Overview
10.6.3 Viatris Inhalation Sevoflurane Anaesthetic Agent Product Market Performance
10.6.4 Viatris Business Overview
10.6.5 Viatris Recent Developments
10.7 PT Novell Pharmaceutical
10.7.1 PT Novell Pharmaceutical Basic Information
10.7.2 PT Novell Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Product Overview
10.7.3 PT Novell Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Product Market Performance
10.7.4 PT Novell Pharmaceutical Business Overview
10.7.5 PT Novell Pharmaceutical Recent Developments
10.8 Lunan Pharma
10.8.1 Lunan Pharma Basic Information
10.8.2 Lunan Pharma Inhalation Sevoflurane Anaesthetic Agent Product Overview
10.8.3 Lunan Pharma Inhalation Sevoflurane Anaesthetic Agent Product Market Performance
10.8.4 Lunan Pharma Business Overview
10.8.5 Lunan Pharma Recent Developments
11 INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET FORECAST BY REGION
11.1 Global Inhalation Sevoflurane Anaesthetic Agent Market Size Forecast
11.2 Global Inhalation Sevoflurane Anaesthetic Agent Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Inhalation Sevoflurane Anaesthetic Agent Market Size Forecast by Country
11.2.3 Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Market Size Forecast by Region
11.2.4 South America Inhalation Sevoflurane Anaesthetic Agent Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Inhalation Sevoflurane Anaesthetic Agent by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Inhalation Sevoflurane Anaesthetic Agent Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Inhalation Sevoflurane Anaesthetic Agent by Type (2026-2035)
12.1.2 Global Inhalation Sevoflurane Anaesthetic Agent Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Inhalation Sevoflurane Anaesthetic Agent by Type (2026-2035)
12.2 Global Inhalation Sevoflurane Anaesthetic Agent Market Forecast by Application (2026-2035)
12.2.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales (K MT) Forecast by Application
12.2.2 Global Inhalation Sevoflurane Anaesthetic Agent Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Inhalation Sevoflurane Anaesthetic Agent Market Size by Type (M USD)
Table 4. Global Inhalation Sevoflurane Anaesthetic Agent Market Size by Application
Table 5. Inhalation Sevoflurane Anaesthetic Agent Market Size Comparison by Region (M USD)
Table 6. Global Inhalation Sevoflurane Anaesthetic Agent Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Inhalation Sevoflurane Anaesthetic Agent Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inhalation Sevoflurane Anaesthetic Agent as of 2025)
Table 11. Global Market Inhalation Sevoflurane Anaesthetic Agent Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Inhalation Sevoflurane Anaesthetic Agent Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Inhalation Sevoflurane Anaesthetic Agent Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Type (K MT)
Table 27. Global Inhalation Sevoflurane Anaesthetic Agent Market Size by Type (M USD)
Table 28. Global Inhalation Sevoflurane Anaesthetic Agent Sales (K MT) by Type (2020-2025)
Table 29. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type (2020-2025)
Table 30. Global Inhalation Sevoflurane Anaesthetic Agent Market Size (M USD) by Type (2020-2025)
Table 31. Global Inhalation Sevoflurane Anaesthetic Agent Market Share by Type (2020-2025)
Table 32. Global Inhalation Sevoflurane Anaesthetic Agent Price (USD/KG) by Type (2020-2025)
Table 33. Global Inhalation Sevoflurane Anaesthetic Agent Sales (K MT) by Application
Table 34. Global Inhalation Sevoflurane Anaesthetic Agent Market Size by Application
Table 35. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2020-2025) & (K MT)
Table 36. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application (2020-2025)
Table 37. Global Inhalation Sevoflurane Anaesthetic Agent Market Size by Application (2020-2025) & (M USD)
Table 38. Global Inhalation Sevoflurane Anaesthetic Agent Market Share by Application (2020-2025)
Table 39. Global Inhalation Sevoflurane Anaesthetic Agent Sales Growth Rate by Application (2020-2025)
Table 40. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Region (2020-2025) & (K MT)
Table 41. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Region (2020-2025)
Table 42. Global Inhalation Sevoflurane Anaesthetic Agent Market Size by Region (2020-2025) & (M USD)
Table 43. Global Inhalation Sevoflurane Anaesthetic Agent Market Size by Region (2020-2025)
Table 44. North America Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2020-2025) & (K MT)
Table 45. North America Inhalation Sevoflurane Anaesthetic Agent Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2020-2025) & (K MT)
Table 47. Europe Inhalation Sevoflurane Anaesthetic Agent Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Market Size by Region (2020-2025) & (M USD)
Table 50. South America Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2020-2025) & (K MT)
Table 51. South America Inhalation Sevoflurane Anaesthetic Agent Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Market Size by Region (2020-2025) & (M USD)
Table 54. Global Inhalation Sevoflurane Anaesthetic Agent Production (K MT) by Region(2020-2025)
Table 55. Global Inhalation Sevoflurane Anaesthetic Agent Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Region (2020-2025)
Table 57. Global Inhalation Sevoflurane Anaesthetic Agent Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Inhalation Sevoflurane Anaesthetic Agent Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Inhalation Sevoflurane Anaesthetic Agent Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Inhalation Sevoflurane Anaesthetic Agent Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Inhalation Sevoflurane Anaesthetic Agent Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Hengrui Basic Information
Table 63. Hengrui Inhalation Sevoflurane Anaesthetic Agent Product Overview
Table 64. Hengrui Inhalation Sevoflurane Anaesthetic Agent Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Hengrui Business Overview
Table 66. Hengrui SWOT Analysis
Table 67. Hengrui Recent Developments
Table 68. Baxter Basic Information
Table 69. Baxter Inhalation Sevoflurane Anaesthetic Agent Product Overview
Table 70. Baxter Inhalation Sevoflurane Anaesthetic Agent Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Baxter Business Overview
Table 72. Baxter SWOT Analysis
Table 73. Baxter Recent Developments
Table 74. Maruishi Basic Information
Table 75. Maruishi Inhalation Sevoflurane Anaesthetic Agent Product Overview
Table 76. Maruishi Inhalation Sevoflurane Anaesthetic Agent Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Maruishi Business Overview
Table 78. Maruishi SWOT Analysis
Table 79. Maruishi Recent Developments
Table 80. AbbVie Basic Information
Table 81. AbbVie Inhalation Sevoflurane Anaesthetic Agent Product Overview
Table 82. AbbVie Inhalation Sevoflurane Anaesthetic Agent Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. AbbVie Business Overview
Table 84. AbbVie Recent Developments
Table 85. Piramal Basic Information
Table 86. Piramal Inhalation Sevoflurane Anaesthetic Agent Product Overview
Table 87. Piramal Inhalation Sevoflurane Anaesthetic Agent Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Piramal Business Overview
Table 89. Piramal Recent Developments
Table 90. Viatris Basic Information
Table 91. Viatris Inhalation Sevoflurane Anaesthetic Agent Product Overview
Table 92. Viatris Inhalation Sevoflurane Anaesthetic Agent Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Viatris Business Overview
Table 94. Viatris Recent Developments
Table 95. PT Novell Pharmaceutical Basic Information
Table 96. PT Novell Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Product Overview
Table 97. PT Novell Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. PT Novell Pharmaceutical Business Overview
Table 99. PT Novell Pharmaceutical Recent Developments
Table 100. Lunan Pharma Basic Information
Table 101. Lunan Pharma Inhalation Sevoflurane Anaesthetic Agent Product Overview
Table 102. Lunan Pharma Inhalation Sevoflurane Anaesthetic Agent Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Lunan Pharma Business Overview
Table 104. Lunan Pharma Recent Developments
Table 105. Global Inhalation Sevoflurane Anaesthetic Agent Sales Forecast by Region (2026-2035) & (K MT)
Table 106. Global Inhalation Sevoflurane Anaesthetic Agent Market Size Forecast by Region (2026-2035) & (M USD)
Table 107. North America Inhalation Sevoflurane Anaesthetic Agent Sales Forecast by Country (2026-2035) & (K MT)
Table 108. North America Inhalation Sevoflurane Anaesthetic Agent Market Size Forecast by Country (2026-2035) & (M USD)
Table 109. Europe Inhalation Sevoflurane Anaesthetic Agent Sales Forecast by Country (2026-2035) & (K MT)
Table 110. Europe Inhalation Sevoflurane Anaesthetic Agent Market Size Forecast by Country (2026-2035) & (M USD)
Table 111. Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Sales Forecast by Region (2026-2035) & (K MT)
Table 112. Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Market Size Forecast by Region (2026-2035) & (M USD)
Table 113. South America Inhalation Sevoflurane Anaesthetic Agent Sales Forecast by Country (2026-2035) & (K MT)
Table 114. South America Inhalation Sevoflurane Anaesthetic Agent Market Size Forecast by Country (2026-2035) & (M USD)
Table 115. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Sales Forecast by Country (2026-2035) & (Units)
Table 116. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Market Size Forecast by Country (2026-2035) & (M USD)
Table 117. Global Inhalation Sevoflurane Anaesthetic Agent Sales Forecast by Type (2026-2035) & (K MT)
Table 118. Global Inhalation Sevoflurane Anaesthetic Agent Market Size Forecast by Type (2026-2035) & (M USD)
Table 119. Global Inhalation Sevoflurane Anaesthetic Agent Price Forecast by Type (2026-2035) & (USD/KG)
Table 120. Global Inhalation Sevoflurane Anaesthetic Agent Sales (K MT) Forecast by Application (2026-2035)
Table 121. Global Inhalation Sevoflurane Anaesthetic Agent Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Inhalation Sevoflurane Anaesthetic Agent Market Size by Type (M USD)
Table 4. Global Inhalation Sevoflurane Anaesthetic Agent Market Size by Application
Table 5. Inhalation Sevoflurane Anaesthetic Agent Market Size Comparison by Region (M USD)
Table 6. Global Inhalation Sevoflurane Anaesthetic Agent Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Inhalation Sevoflurane Anaesthetic Agent Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inhalation Sevoflurane Anaesthetic Agent as of 2025)
Table 11. Global Market Inhalation Sevoflurane Anaesthetic Agent Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Inhalation Sevoflurane Anaesthetic Agent Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Inhalation Sevoflurane Anaesthetic Agent Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Type (K MT)
Table 27. Global Inhalation Sevoflurane Anaesthetic Agent Market Size by Type (M USD)
Table 28. Global Inhalation Sevoflurane Anaesthetic Agent Sales (K MT) by Type (2020-2025)
Table 29. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type (2020-2025)
Table 30. Global Inhalation Sevoflurane Anaesthetic Agent Market Size (M USD) by Type (2020-2025)
Table 31. Global Inhalation Sevoflurane Anaesthetic Agent Market Share by Type (2020-2025)
Table 32. Global Inhalation Sevoflurane Anaesthetic Agent Price (USD/KG) by Type (2020-2025)
Table 33. Global Inhalation Sevoflurane Anaesthetic Agent Sales (K MT) by Application
Table 34. Global Inhalation Sevoflurane Anaesthetic Agent Market Size by Application
Table 35. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2020-2025) & (K MT)
Table 36. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application (2020-2025)
Table 37. Global Inhalation Sevoflurane Anaesthetic Agent Market Size by Application (2020-2025) & (M USD)
Table 38. Global Inhalation Sevoflurane Anaesthetic Agent Market Share by Application (2020-2025)
Table 39. Global Inhalation Sevoflurane Anaesthetic Agent Sales Growth Rate by Application (2020-2025)
Table 40. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Region (2020-2025) & (K MT)
Table 41. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Region (2020-2025)
Table 42. Global Inhalation Sevoflurane Anaesthetic Agent Market Size by Region (2020-2025) & (M USD)
Table 43. Global Inhalation Sevoflurane Anaesthetic Agent Market Size by Region (2020-2025)
Table 44. North America Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2020-2025) & (K MT)
Table 45. North America Inhalation Sevoflurane Anaesthetic Agent Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2020-2025) & (K MT)
Table 47. Europe Inhalation Sevoflurane Anaesthetic Agent Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Market Size by Region (2020-2025) & (M USD)
Table 50. South America Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2020-2025) & (K MT)
Table 51. South America Inhalation Sevoflurane Anaesthetic Agent Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Market Size by Region (2020-2025) & (M USD)
Table 54. Global Inhalation Sevoflurane Anaesthetic Agent Production (K MT) by Region(2020-2025)
Table 55. Global Inhalation Sevoflurane Anaesthetic Agent Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Region (2020-2025)
Table 57. Global Inhalation Sevoflurane Anaesthetic Agent Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Inhalation Sevoflurane Anaesthetic Agent Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Inhalation Sevoflurane Anaesthetic Agent Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Inhalation Sevoflurane Anaesthetic Agent Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Inhalation Sevoflurane Anaesthetic Agent Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Hengrui Basic Information
Table 63. Hengrui Inhalation Sevoflurane Anaesthetic Agent Product Overview
Table 64. Hengrui Inhalation Sevoflurane Anaesthetic Agent Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Hengrui Business Overview
Table 66. Hengrui SWOT Analysis
Table 67. Hengrui Recent Developments
Table 68. Baxter Basic Information
Table 69. Baxter Inhalation Sevoflurane Anaesthetic Agent Product Overview
Table 70. Baxter Inhalation Sevoflurane Anaesthetic Agent Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Baxter Business Overview
Table 72. Baxter SWOT Analysis
Table 73. Baxter Recent Developments
Table 74. Maruishi Basic Information
Table 75. Maruishi Inhalation Sevoflurane Anaesthetic Agent Product Overview
Table 76. Maruishi Inhalation Sevoflurane Anaesthetic Agent Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Maruishi Business Overview
Table 78. Maruishi SWOT Analysis
Table 79. Maruishi Recent Developments
Table 80. AbbVie Basic Information
Table 81. AbbVie Inhalation Sevoflurane Anaesthetic Agent Product Overview
Table 82. AbbVie Inhalation Sevoflurane Anaesthetic Agent Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. AbbVie Business Overview
Table 84. AbbVie Recent Developments
Table 85. Piramal Basic Information
Table 86. Piramal Inhalation Sevoflurane Anaesthetic Agent Product Overview
Table 87. Piramal Inhalation Sevoflurane Anaesthetic Agent Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Piramal Business Overview
Table 89. Piramal Recent Developments
Table 90. Viatris Basic Information
Table 91. Viatris Inhalation Sevoflurane Anaesthetic Agent Product Overview
Table 92. Viatris Inhalation Sevoflurane Anaesthetic Agent Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Viatris Business Overview
Table 94. Viatris Recent Developments
Table 95. PT Novell Pharmaceutical Basic Information
Table 96. PT Novell Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Product Overview
Table 97. PT Novell Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. PT Novell Pharmaceutical Business Overview
Table 99. PT Novell Pharmaceutical Recent Developments
Table 100. Lunan Pharma Basic Information
Table 101. Lunan Pharma Inhalation Sevoflurane Anaesthetic Agent Product Overview
Table 102. Lunan Pharma Inhalation Sevoflurane Anaesthetic Agent Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Lunan Pharma Business Overview
Table 104. Lunan Pharma Recent Developments
Table 105. Global Inhalation Sevoflurane Anaesthetic Agent Sales Forecast by Region (2026-2035) & (K MT)
Table 106. Global Inhalation Sevoflurane Anaesthetic Agent Market Size Forecast by Region (2026-2035) & (M USD)
Table 107. North America Inhalation Sevoflurane Anaesthetic Agent Sales Forecast by Country (2026-2035) & (K MT)
Table 108. North America Inhalation Sevoflurane Anaesthetic Agent Market Size Forecast by Country (2026-2035) & (M USD)
Table 109. Europe Inhalation Sevoflurane Anaesthetic Agent Sales Forecast by Country (2026-2035) & (K MT)
Table 110. Europe Inhalation Sevoflurane Anaesthetic Agent Market Size Forecast by Country (2026-2035) & (M USD)
Table 111. Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Sales Forecast by Region (2026-2035) & (K MT)
Table 112. Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Market Size Forecast by Region (2026-2035) & (M USD)
Table 113. South America Inhalation Sevoflurane Anaesthetic Agent Sales Forecast by Country (2026-2035) & (K MT)
Table 114. South America Inhalation Sevoflurane Anaesthetic Agent Market Size Forecast by Country (2026-2035) & (M USD)
Table 115. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Sales Forecast by Country (2026-2035) & (Units)
Table 116. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Market Size Forecast by Country (2026-2035) & (M USD)
Table 117. Global Inhalation Sevoflurane Anaesthetic Agent Sales Forecast by Type (2026-2035) & (K MT)
Table 118. Global Inhalation Sevoflurane Anaesthetic Agent Market Size Forecast by Type (2026-2035) & (M USD)
Table 119. Global Inhalation Sevoflurane Anaesthetic Agent Price Forecast by Type (2026-2035) & (USD/KG)
Table 120. Global Inhalation Sevoflurane Anaesthetic Agent Sales (K MT) Forecast by Application (2026-2035)
Table 121. Global Inhalation Sevoflurane Anaesthetic Agent Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Inhalation Sevoflurane Anaesthetic Agent
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Inhalation Sevoflurane Anaesthetic Agent Market Size (M USD), 2025-2035
Figure 5. Global Inhalation Sevoflurane Anaesthetic Agent Market Size (M USD) (2020-2035)
Figure 6. Global Inhalation Sevoflurane Anaesthetic Agent Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Inhalation Sevoflurane Anaesthetic Agent Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Inhalation Sevoflurane Anaesthetic Agent Product Life Cycle
Figure 13. Inhalation Sevoflurane Anaesthetic Agent Sales Share by Manufacturers in 2025
Figure 14. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Share by Manufacturers in 2025
Figure 15. Inhalation Sevoflurane Anaesthetic Agent Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Inhalation Sevoflurane Anaesthetic Agent Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Inhalation Sevoflurane Anaesthetic Agent Revenue in 2025
Figure 18. Industry Chain Map of Inhalation Sevoflurane Anaesthetic Agent
Figure 19. Global Inhalation Sevoflurane Anaesthetic Agent Market PEST Analysis
Figure 20. Global Inhalation Sevoflurane Anaesthetic Agent Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Inhalation Sevoflurane Anaesthetic Agent Market Share by Type
Figure 27. Sales Market Share of Inhalation Sevoflurane Anaesthetic Agent by Type (2020-2025)
Figure 28. Sales Market Share of Inhalation Sevoflurane Anaesthetic Agent by Type in 2025
Figure 29. Market Share of Inhalation Sevoflurane Anaesthetic Agent by Type (2020-2025)
Figure 30. Market Share of Inhalation Sevoflurane Anaesthetic Agent by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Inhalation Sevoflurane Anaesthetic Agent Market Share by Application
Figure 33. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application (2020-2025)
Figure 34. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application in 2025
Figure 35. Global Inhalation Sevoflurane Anaesthetic Agent Market Share by Application (2020-2025)
Figure 36. Global Inhalation Sevoflurane Anaesthetic Agent Market Share by Application in 2025
Figure 37. Global Inhalation Sevoflurane Anaesthetic Agent Sales Growth Rate by Application (2020-2025)
Figure 38. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Region (2020-2025)
Figure 39. Global Inhalation Sevoflurane Anaesthetic Agent Market Size by Region (2020-2025)
Figure 40. North America Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Country in 2024
Figure 43. North America Inhalation Sevoflurane Anaesthetic Agent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Inhalation Sevoflurane Anaesthetic Agent Market Size by Country in 2024
Figure 45. U.S. Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Inhalation Sevoflurane Anaesthetic Agent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Inhalation Sevoflurane Anaesthetic Agent Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Inhalation Sevoflurane Anaesthetic Agent Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Inhalation Sevoflurane Anaesthetic Agent Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Inhalation Sevoflurane Anaesthetic Agent Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Country in 2024
Figure 53. Europe Inhalation Sevoflurane Anaesthetic Agent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Inhalation Sevoflurane Anaesthetic Agent Market Size by Country in 2024
Figure 55. Germany Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Inhalation Sevoflurane Anaesthetic Agent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Inhalation Sevoflurane Anaesthetic Agent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Inhalation Sevoflurane Anaesthetic Agent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Inhalation Sevoflurane Anaesthetic Agent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Inhalation Sevoflurane Anaesthetic Agent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Region in 2024
Figure 67. Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Market Size by Region in 2024
Figure 68. China Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Inhalation Sevoflurane Anaesthetic Agent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Inhalation Sevoflurane Anaesthetic Agent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Inhalation Sevoflurane Anaesthetic Agent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Inhalation Sevoflurane Anaesthetic Agent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Inhalation Sevoflurane Anaesthetic Agent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (K MT)
Figure 79. South America Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Country in 2024
Figure 80. South America Inhalation Sevoflurane Anaesthetic Agent Market Size and Growth Rate (M USD)
Figure 81. South America Inhalation Sevoflurane Anaesthetic Agent Market Size by Country in 2024
Figure 82. Brazil Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Inhalation Sevoflurane Anaesthetic Agent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Inhalation Sevoflurane Anaesthetic Agent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Inhalation Sevoflurane Anaesthetic Agent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Market Size by Region in 2024
Figure 92. Saudi Arabia Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Inhalation Sevoflurane Anaesthetic Agent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Inhalation Sevoflurane Anaesthetic Agent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Inhalation Sevoflurane Anaesthetic Agent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Inhalation Sevoflurane Anaesthetic Agent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Inhalation Sevoflurane Anaesthetic Agent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Inhalation Sevoflurane Anaesthetic Agent Production Market Share by Region (2020-2025)
Figure 103. North America Inhalation Sevoflurane Anaesthetic Agent Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Inhalation Sevoflurane Anaesthetic Agent Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Inhalation Sevoflurane Anaesthetic Agent Production (K MT) Growth Rate (2020-2025)
Figure 106. China Inhalation Sevoflurane Anaesthetic Agent Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Inhalation Sevoflurane Anaesthetic Agent Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Inhalation Sevoflurane Anaesthetic Agent Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Inhalation Sevoflurane Anaesthetic Agent Market Share Forecast by Type (2026-2035)
Figure 111. Global Inhalation Sevoflurane Anaesthetic Agent Sales Forecast by Application (2026-2035)
Figure 112. Global Inhalation Sevoflurane Anaesthetic Agent Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Inhalation Sevoflurane Anaesthetic Agent
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Inhalation Sevoflurane Anaesthetic Agent Market Size (M USD), 2025-2035
Figure 5. Global Inhalation Sevoflurane Anaesthetic Agent Market Size (M USD) (2020-2035)
Figure 6. Global Inhalation Sevoflurane Anaesthetic Agent Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Inhalation Sevoflurane Anaesthetic Agent Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Inhalation Sevoflurane Anaesthetic Agent Product Life Cycle
Figure 13. Inhalation Sevoflurane Anaesthetic Agent Sales Share by Manufacturers in 2025
Figure 14. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Share by Manufacturers in 2025
Figure 15. Inhalation Sevoflurane Anaesthetic Agent Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Inhalation Sevoflurane Anaesthetic Agent Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Inhalation Sevoflurane Anaesthetic Agent Revenue in 2025
Figure 18. Industry Chain Map of Inhalation Sevoflurane Anaesthetic Agent
Figure 19. Global Inhalation Sevoflurane Anaesthetic Agent Market PEST Analysis
Figure 20. Global Inhalation Sevoflurane Anaesthetic Agent Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Inhalation Sevoflurane Anaesthetic Agent Market Share by Type
Figure 27. Sales Market Share of Inhalation Sevoflurane Anaesthetic Agent by Type (2020-2025)
Figure 28. Sales Market Share of Inhalation Sevoflurane Anaesthetic Agent by Type in 2025
Figure 29. Market Share of Inhalation Sevoflurane Anaesthetic Agent by Type (2020-2025)
Figure 30. Market Share of Inhalation Sevoflurane Anaesthetic Agent by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Inhalation Sevoflurane Anaesthetic Agent Market Share by Application
Figure 33. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application (2020-2025)
Figure 34. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application in 2025
Figure 35. Global Inhalation Sevoflurane Anaesthetic Agent Market Share by Application (2020-2025)
Figure 36. Global Inhalation Sevoflurane Anaesthetic Agent Market Share by Application in 2025
Figure 37. Global Inhalation Sevoflurane Anaesthetic Agent Sales Growth Rate by Application (2020-2025)
Figure 38. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Region (2020-2025)
Figure 39. Global Inhalation Sevoflurane Anaesthetic Agent Market Size by Region (2020-2025)
Figure 40. North America Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Country in 2024
Figure 43. North America Inhalation Sevoflurane Anaesthetic Agent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Inhalation Sevoflurane Anaesthetic Agent Market Size by Country in 2024
Figure 45. U.S. Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Inhalation Sevoflurane Anaesthetic Agent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Inhalation Sevoflurane Anaesthetic Agent Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Inhalation Sevoflurane Anaesthetic Agent Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Inhalation Sevoflurane Anaesthetic Agent Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Inhalation Sevoflurane Anaesthetic Agent Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Country in 2024
Figure 53. Europe Inhalation Sevoflurane Anaesthetic Agent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Inhalation Sevoflurane Anaesthetic Agent Market Size by Country in 2024
Figure 55. Germany Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Inhalation Sevoflurane Anaesthetic Agent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Inhalation Sevoflurane Anaesthetic Agent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Inhalation Sevoflurane Anaesthetic Agent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Inhalation Sevoflurane Anaesthetic Agent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Inhalation Sevoflurane Anaesthetic Agent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Region in 2024
Figure 67. Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Market Size by Region in 2024
Figure 68. China Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Inhalation Sevoflurane Anaesthetic Agent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Inhalation Sevoflurane Anaesthetic Agent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Inhalation Sevoflurane Anaesthetic Agent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Inhalation Sevoflurane Anaesthetic Agent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Inhalation Sevoflurane Anaesthetic Agent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (K MT)
Figure 79. South America Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Country in 2024
Figure 80. South America Inhalation Sevoflurane Anaesthetic Agent Market Size and Growth Rate (M USD)
Figure 81. South America Inhalation Sevoflurane Anaesthetic Agent Market Size by Country in 2024
Figure 82. Brazil Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Inhalation Sevoflurane Anaesthetic Agent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Inhalation Sevoflurane Anaesthetic Agent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Inhalation Sevoflurane Anaesthetic Agent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Market Size by Region in 2024
Figure 92. Saudi Arabia Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Inhalation Sevoflurane Anaesthetic Agent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Inhalation Sevoflurane Anaesthetic Agent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Inhalation Sevoflurane Anaesthetic Agent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Inhalation Sevoflurane Anaesthetic Agent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Inhalation Sevoflurane Anaesthetic Agent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Inhalation Sevoflurane Anaesthetic Agent Production Market Share by Region (2020-2025)
Figure 103. North America Inhalation Sevoflurane Anaesthetic Agent Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Inhalation Sevoflurane Anaesthetic Agent Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Inhalation Sevoflurane Anaesthetic Agent Production (K MT) Growth Rate (2020-2025)
Figure 106. China Inhalation Sevoflurane Anaesthetic Agent Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Inhalation Sevoflurane Anaesthetic Agent Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Inhalation Sevoflurane Anaesthetic Agent Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Inhalation Sevoflurane Anaesthetic Agent Market Share Forecast by Type (2026-2035)
Figure 111. Global Inhalation Sevoflurane Anaesthetic Agent Sales Forecast by Application (2026-2035)
Figure 112. Global Inhalation Sevoflurane Anaesthetic Agent Market Share Forecast by Application (2026-2035)
